Global Plasma Protein Therapeutics Market Size, Share & Industry Trends Analysis Report By End User, By Product Type (Immunoglobulin, Albumin, Plasma derived factor VIII, and Others), By Application, By Regional Outlook and Forecast, 2023 - 2029

The Global Plasma Protein Therapeutics Market size is expected to reach $39.1 billion by 2029, rising at a market growth of 5.5% CAGR during the forecast period.

Pharmaceuticals known as plasma protein therapeutics are created from proteins extracted from human blood plasma. The biological actions of these proteins include controlling immunological response, blood clotting, and preserving the body's fluid balance. Blood problems, immunological deficiencies, as well as genetic disorders are just a few of the ailments that are treated with plasma protein therapeutics. They are frequently given by injection or infusion, and careful monitoring is necessary to ensure appropriate dosage and reduce any potential side effects.

Plasma is the form of fluid or a part of blood in which cellular components like leucocytes, red blood cells, and platelets are suspended. Plasma makes up 55% of total blood, with 89% of it being water, 2% salt, 3% lipids, and 6% protein. The 2,000–4,000 distinct proteins that make up the plasma proteins (60 g/L) have varying concentrations of hormones as well as about 40 mg/mL (albumin), and their total weight is 60 g/L.

The absence or deficit of a plasma protein could be fatal since each component protein in the human body has a distinct purpose in maintaining homeostasis. Plasma proteins are noted as being absent or dysfunctional in numerous clinical pathological circumstances. In clinical settings, fresh frozen plasma (FFP) or plasma for transfusion both are employed.

Plasma for transfusion is utilized in the treatment of general clotting factor deficiencies as well as in the correction of hyper-fibrinolysis in thrombolysis, replacement of deficient factors during plasmapheresis therapy. The method is also used in isolating deficiencies of clotting factor in lack of purified plasma-derived products. Safety precautions, such as a quarantine time and/or pathogen inactivation, are used in addition to donor exclusion, donor information, and donation screening to avoid the spread of blood-borne illnesses that are transferred during transfusions.

COVID-19 Impact Analysis

Large opportunities for COVID-19 management drug development were offered by the dearth of these medicines in many developed nations. Due to the increasing demand for COVID-19 vaccines and medications, future growth in the pharmaceutical and biotechnology industries is projected. This is expected to have a substantial influence on the demand for plasma protein. In addition, the market is anticipated to expand as a result of more plasma protein therapies product launches and related research projects. Therefore, it can be stated conclusively that the pandemic had a positive impact on the plasma protein therapeutics market.

Market Growth Factors

Growing funding for technological innovation

The market for plasma protein therapeutics is projected to grow due to technological developments in efficient and affordable methods for fractionating proteins from plasma. More R&D is being conducted because of the rising infectious diseases like hepatitis A&B, rabies, tetanus, and varicella. In addition, over 200 life-threatening diseases affect the immune or neurological systems, including chronic inflammatory demyelinating polyneuropathy (CIDP), idiopathic thrombocytopenic purpura. Hence, all these factors will promote the market's growth throughout the forecast period.

Rising need for immunoglobulins for the treatment of various disorders

A significant amount of plasma is used in Ig's widespread off-label usage. Examples of the most prevalent off-label IVIG usage include multifocal motor neuropathy (MMN), infant hemolytic illness, acute panautonomic polyneuropathy, autoimmune mucocutaneous blistering disorders, and acute cardiomyopathy. Due to ongoing advancements in diagnosis and higher life expectancy, the clinical demand for these medications has surged over the past several years. It is predicted to continue on its upward trajectory. The demand for Ig is rising due to immunological inadequacies as well as the chronic usage of off-label prescribing in various indications, especially as part of the treatment of certain neurological diseases.

Market Restraining Factors

Risk of market harm from reimbursement issues and strict regulation

Emerging nations' plasma collection requirements differ from those of fractionators. These areas adhere to stringent laws and norms regarding the caliber of their operations, beginning with the caliber of the raw materials. For plasma, specific fractionators have been created. For instance, the plasma pool used for fractionation must be checked for Parvovirus B, hepatitis A, B, and C, as well as HIV, by the European health authorities. Unfortunately, many facilities' blood collection efforts frequently fail to meet these requirements, wasting some recovered plasma. There is increasing pressure on health finances. Therefore, all these factors may hamper the expansion of the market in the coming years.

Product Type Outlook

Based on product type, the plasma protein therapeutics market is categorized into immunoglobulin, albumin, plasma derived factor VIII, and others. The immunoglobulin segment garnered the highest revenue share in the plasma protein therapeutics market in 2022. The growth of the segment is owed to the rising use of immunoglobulins in treating various diseases. Immunoglobulins are proteins that control the immune system and eliminate foreign invaders like bacteria and viruses. Additionally, it is employed in treating autoimmune diseases and primary and secondary immunodeficiency.

Application Outlook

On the basis of application, the plasma protein therapeutics market is divided into hemophilia, idiopathic thrombocytopenic purpura, primary immunodeficiency disorder, and others. The primary immunodeficiency disorder segment recorded a significant revenue share in the plasma protein therapeutics market in 2022. Primary Immunodeficiency Diseases (PID) are more than 430 uncommon in number, and are long-lasting illnesses brought on by immune system flaws. PID affects over 6.0 million individuals globally. Therefore, the demand for plasma protein therapeutics to treat PID is expected to grow significantly throughout the projection period.

End User Outlook

Based on end user, the plasma protein therapeutics market is segmented into hospitals and others. The others segment garnered a considerable growth rate in the plasma protein therapeutics market in 2022. This growth can be attributed to a rise in the number of people visiting hospitals with autoimmune diseases like hemophilia and the accessibility of protein therapies in hospitals. The use of clinics and other patient care infrastructure has expanded as a result of its affordability, ease of booking appointments, and commitment to patient accessibility and convenience.

Plasma Protein Therapeutics Market Report Coverage

Report Attribute	Details
Market size value in 2022	USD 27.1 Billion
Market size forecast in 2029	USD 39.1 Billion
Base Year	2022
Historical Period	2019 to 2021
Forecast Period	2023 to 2029
Revenue Growth Rate	CAGR of 5.5% from 2023 to 2029
Number of Pages	231
Number of Table	365
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered	Application, Product Type, End User, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Growing funding for technological innovation Rising need for immunoglobulins for the treatment of various disorders
Restraints	Risk of market harm from reimbursement issues and strict regulation

Regional Outlook

On the basis of region, the plasma protein therapeutics market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the plasma protein therapeutics market in 2022. The prevalence of immunological illnesses is rising, uncommon diseases are becoming more common, and research funding for plasma protein therapies is increasing in North America. Additionally, an increase in the number of major companies producing plasma protein therapies contributes to the market expansion in this region. High purchasing power and the availability of well-established healthcare systems are further factors anticipated to fuel market expansion.

Free Valuable Insights: Global Plasma Protein Therapeutics Market size to reach USD 39.1 Billion by 2029

KBV Cardinal Matrix - Plasma Protein Therapeutics Market Competition Analysis

The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix; CSL Limited (CSL Behring), Baxter International, Inc., Bayer AG, and Takeda Pharmaceutical Company Limited are the forerunners in the Plasma Protein Therapeutics Market. Companies such as Grifols, S.A., Kedrion S.p.A, and ADMA Biologics, Inc. are some of the key innovators in Plasma Protein Therapeutics Market.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Bayer AG, Abeona Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Grifols, S.A., Baxter International, Inc., Kedrion S.p.A, Octapharma AG, CSL Limited (CSL Behring), Taibang Biological Group Co., Ltd and ADMA Biologics, Inc.

Recent Strategies Deployed in Plasma Protein Therapeutics Market

» Partnerships, Collaborations and Agreements:

• Oct-2022: Takeda partnered with United Nations Institute for Training and Research (UNITAR), a Switzerland headquartered research and training institute. The partnership involves launching the educational program with the intention to create an UN-based platform that would enable stakeholders to gather and discuss solutions related to plasma and plasma-derived therapy shortfalls.
• Sep-2022: Grifols entered into an agreement with the National Blood Authority of Canada, a Canadian provider of Blood Services. With this agreement, the entities aimed to accelerate the self-sufficiency of the country in terms of immunoglobulin medicines, which are necessary plasma-protein therapies in order to cure a broad range of immunodeficiencies as well as other medical malignancies.
• Feb-2022: Grifols came into collaboration with Endpoint Health, a US-based therapeutics company. The collaboration includes Grifols supporting through its expertise in plasma protein therapies and would act as an exclusive supplier of AT-III. AT-III is a plasma protein that is intended for the treatment of patients with blood clotting. This collaboration reinforces Grifols plasma economics.

» Trials and Approvals:

• Feb-2023: Octapharma received approval from Europea Medical Authorities for the lyophilized presentation of the well-established octaplasLG, an S/D treated plasma for transfusion. The approved product would be sold in Europe in the form of powder and solvent. The octaplasLG can be reconstituted in a short span of time and can be stored at room temperature. Further, the approval complements the company's commitment to supporting the prevention of uncontrolled hemorrhage.
• Feb-2023: FDA approved ADMA's eighth plasma collection center located in Hammond, Louisiana, United States of America. This FDA approval enables the company's eighth collection center to collect, and introduce into interstate commerce, human source plasma. Further, this approval complements the company's aim to be plasma self-sufficient and supports the company in improving its profitability.

» Acquisitions and Mergers:

• Mar-2023: Takeda took over Nimbus Lakshmi from Nimbus Therapeutics. Nimbus Lakshmi is a US-based developer of medicines for various autoimmune diseases. The addition of Nimbus Lakshmi reinforces Takeda's evolving pipeline and perfectly aligns with its strategy and competence.
• Dec-2022: Kedrion acquired UNICAplasma s.r.o and UNICAplasma Morava s.r.o., Czech companies that operate five plasma collection centers in the Czech Republic. The addition of the two Czech-based companies would add significant value to the acquiring company and would further provide Kedrion with high-quality plasma for their production facilities, which in turn would enable the company to develop therapeutics for rare conditions.
• Jan-2022: Kedrion formed a merger with Bio Products Laboratory, a company involved in the manufacture of human blood plasma products. Following this merger, the companies aimed to manufacture and develop a strong player within the global plasma derivatives market. Moreover, the new merger would allow the companies to treat patients with hazardous and rare conditions with human blood plasma-derived medicines.
• Oct-2202: Kedrion Biopharma took over Prometic, a life sciences business. Through this acquisition, the company aimed to integrate the first-ever FDA-approved Congenital Plasminogen Deficiency treatment medicine of Prometic, Ryplazim. Furthermore, this acquisition would allow Kedrion to expand its footprint throughout North America.
• Aug-2021: Bayer acquired Vividion Therapeutics, a US-based developer of a drug discovery platform. The addition of Vividion reinforces the acquiring company's small molecule capabilities and broadens its presence into new modalities. Further, this acquisition acts as a base for Bayer's strategy to power its pipeline with innovation.
• Mar-2021: Takeda completed its acquisition of Maverick Therapeutics, a biopharmaceutical company. Under this acquisition, Takeda would leverage the COBRA T-cell engager platform of Maverick to develop more efficient therapies.
• Mar-2021: Grifols acquired BPL Plasma, a subsidiary of Bio Products Laboratory. Through this acquisition, the company aimed to reinforce, expand, and diversify its robust network capacity as well as centers in order to deliver life-improving plasma-derived medicines.

» Geographical Expansions:

• Mar-2023: Takeda expanded its global footprint by setting up a new facility intended for plasma-derived therapies. The new facility is located in Japan. The therapy developing facility reinforces the company's manufacturing and supply capabilities and further enables the company to better take care of the evolving needs for Plasma-Derived Therapies (PDTs) in Japan as well as the rest of the world.
• Oct-2022: Grifols established a new manufacturing facility in Ireland. The new facility is established to cater to the evolving needs for plasma-based medicines. The new facility in Ireland triples the company's annual filling production capacity. Further, the geographical expansion demonstrates the company's commitment to investing in plasma medicines infrastructure.
• Sep-2022: Takeda expanded its global footprint by setting up a new manufacturing facility in Belgium and expanding its already existing warehouse in Lessines, Belgium. The new facility in Belgium would be equipped with a water recycling system that would reduce freshwater consumption by 90%.

Scope of the Study

Market Segments Covered in the Report:

By End User

• Hospitals
• Others

By Product Type

• Immunoglobulin
• Albumin
• Plasma derived factor VIII
• Others

By Application

• Hemophilia
• Idiopathic Thrombocytopenic Purpura
• Primary Immunodeficiency Disorder
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Bayer AG
• Abeona Therapeutics, Inc.
• Takeda Pharmaceutical Company Limited
• Grifols, S.A.
• Baxter International, Inc.
• Kedrion S.p.A
• Octapharma AG
• CSL Limited (CSL Behring)
• Taibang Biological Group Co., Ltd
• ADMA Biologics, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Plasma Protein Therapeutics Market, by End User
1.4.2 Global Plasma Protein Therapeutics Market, by Product Type
1.4.3 Global Plasma Protein Therapeutics Market, by Application
1.4.4 Global Plasma Protein Therapeutics Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Acquisitions and Mergers : 2020, Jun – 2023, Mar) Leading Players

Chapter 4. Global Plasma Protein Therapeutics Market by End User
4.1 Global Hospitals Market by Region
4.2 Global Others Market by Region

Chapter 5. Global Plasma Protein Therapeutics Market by Product Type
5.1 Global Immunoglobulin Market by Region
5.2 Global Albumin Market by Region
5.3 Global Plasma derived factor VIII Market by Region
5.4 Global Others Market by Region

Chapter 6. Global Plasma Protein Therapeutics Market by Application
6.1 Global Hemophilia Market by Region
6.2 Global Idiopathic Thrombocytopenic Purpura Market by Region
6.3 Global Primary Immunodeficiency Disorder Market by Region
6.4 Global Others Market by Region

Chapter 7. Global Plasma Protein Therapeutics Market by Region
7.1 North America Plasma Protein Therapeutics Market
7.1.1 North America Plasma Protein Therapeutics Market by End User
7.1.1.1 North America Hospitals Market by Country
7.1.1.2 North America Others Market by Country
7.1.2 North America Plasma Protein Therapeutics Market by Product Type
7.1.2.1 North America Immunoglobulin Market by Country
7.1.2.2 North America Albumin Market by Country
7.1.2.3 North America Plasma derived factor VIII Market by Country
7.1.2.4 North America Others Market by Country
7.1.3 North America Plasma Protein Therapeutics Market by Application
7.1.3.1 North America Hemophilia Market by Country
7.1.3.2 North America Idiopathic Thrombocytopenic Purpura Market by Country
7.1.3.3 North America Primary Immunodeficiency Disorder Market by Country
7.1.3.4 North America Others Market by Country
7.1.4 North America Plasma Protein Therapeutics Market by Country
7.1.4.1 US Plasma Protein Therapeutics Market
7.1.4.1.1 US Plasma Protein Therapeutics Market by End User
7.1.4.1.2 US Plasma Protein Therapeutics Market by Product Type
7.1.4.1.3 US Plasma Protein Therapeutics Market by Application
7.1.4.2 Canada Plasma Protein Therapeutics Market
7.1.4.2.1 Canada Plasma Protein Therapeutics Market by End User
7.1.4.2.2 Canada Plasma Protein Therapeutics Market by Product Type
7.1.4.2.3 Canada Plasma Protein Therapeutics Market by Application
7.1.4.3 Mexico Plasma Protein Therapeutics Market
7.1.4.3.1 Mexico Plasma Protein Therapeutics Market by End User
7.1.4.3.2 Mexico Plasma Protein Therapeutics Market by Product Type
7.1.4.3.3 Mexico Plasma Protein Therapeutics Market by Application
7.1.4.4 Rest of North America Plasma Protein Therapeutics Market
7.1.4.4.1 Rest of North America Plasma Protein Therapeutics Market by End User
7.1.4.4.2 Rest of North America Plasma Protein Therapeutics Market by Product Type
7.1.4.4.3 Rest of North America Plasma Protein Therapeutics Market by Application
7.2 Europe Plasma Protein Therapeutics Market
7.2.1 Europe Plasma Protein Therapeutics Market by End User
7.2.1.1 Europe Hospitals Market by Country
7.2.1.2 Europe Others Market by Country
7.2.2 Europe Plasma Protein Therapeutics Market by Product Type
7.2.2.1 Europe Immunoglobulin Market by Country
7.2.2.2 Europe Albumin Market by Country
7.2.2.3 Europe Plasma derived factor VIII Market by Country
7.2.2.4 Europe Others Market by Country
7.2.3 Europe Plasma Protein Therapeutics Market by Application
7.2.3.1 Europe Hemophilia Market by Country
7.2.3.2 Europe Idiopathic Thrombocytopenic Purpura Market by Country
7.2.3.3 Europe Primary Immunodeficiency Disorder Market by Country
7.2.3.4 Europe Others Market by Country
7.2.4 Europe Plasma Protein Therapeutics Market by Country
7.2.4.1 Germany Plasma Protein Therapeutics Market
7.2.4.1.1 Germany Plasma Protein Therapeutics Market by End User
7.2.4.1.2 Germany Plasma Protein Therapeutics Market by Product Type
7.2.4.1.3 Germany Plasma Protein Therapeutics Market by Application
7.2.4.2 UK Plasma Protein Therapeutics Market
7.2.4.2.1 UK Plasma Protein Therapeutics Market by End User
7.2.4.2.2 UK Plasma Protein Therapeutics Market by Product Type
7.2.4.2.3 UK Plasma Protein Therapeutics Market by Application
7.2.4.3 France Plasma Protein Therapeutics Market
7.2.4.3.1 France Plasma Protein Therapeutics Market by End User
7.2.4.3.2 France Plasma Protein Therapeutics Market by Product Type
7.2.4.3.3 France Plasma Protein Therapeutics Market by Application
7.2.4.4 Russia Plasma Protein Therapeutics Market
7.2.4.4.1 Russia Plasma Protein Therapeutics Market by End User
7.2.4.4.2 Russia Plasma Protein Therapeutics Market by Product Type
7.2.4.4.3 Russia Plasma Protein Therapeutics Market by Application
7.2.4.5 Spain Plasma Protein Therapeutics Market
7.2.4.5.1 Spain Plasma Protein Therapeutics Market by End User
7.2.4.5.2 Spain Plasma Protein Therapeutics Market by Product Type
7.2.4.5.3 Spain Plasma Protein Therapeutics Market by Application
7.2.4.6 Italy Plasma Protein Therapeutics Market
7.2.4.6.1 Italy Plasma Protein Therapeutics Market by End User
7.2.4.6.2 Italy Plasma Protein Therapeutics Market by Product Type
7.2.4.6.3 Italy Plasma Protein Therapeutics Market by Application
7.2.4.7 Rest of Europe Plasma Protein Therapeutics Market
7.2.4.7.1 Rest of Europe Plasma Protein Therapeutics Market by End User
7.2.4.7.2 Rest of Europe Plasma Protein Therapeutics Market by Product Type
7.2.4.7.3 Rest of Europe Plasma Protein Therapeutics Market by Application
7.3 Asia Pacific Plasma Protein Therapeutics Market
7.3.1 Asia Pacific Plasma Protein Therapeutics Market by End User
7.3.1.1 Asia Pacific Hospitals Market by Country
7.3.1.2 Asia Pacific Others Market by Country
7.3.2 Asia Pacific Plasma Protein Therapeutics Market by Product Type
7.3.2.1 Asia Pacific Immunoglobulin Market by Country
7.3.2.2 Asia Pacific Albumin Market by Country
7.3.2.3 Asia Pacific Plasma derived factor VIII Market by Country
7.3.2.4 Asia Pacific Others Market by Country
7.3.3 Asia Pacific Plasma Protein Therapeutics Market by Application
7.3.3.1 Asia Pacific Hemophilia Market by Country
7.3.3.2 Asia Pacific Idiopathic Thrombocytopenic Purpura Market by Country
7.3.3.3 Asia Pacific Primary Immunodeficiency Disorder Market by Country
7.3.3.4 Asia Pacific Others Market by Country
7.3.4 Asia Pacific Plasma Protein Therapeutics Market by Country
7.3.4.1 China Plasma Protein Therapeutics Market
7.3.4.1.1 China Plasma Protein Therapeutics Market by End User
7.3.4.1.2 China Plasma Protein Therapeutics Market by Product Type
7.3.4.1.3 China Plasma Protein Therapeutics Market by Application
7.3.4.2 Japan Plasma Protein Therapeutics Market
7.3.4.2.1 Japan Plasma Protein Therapeutics Market by End User
7.3.4.2.2 Japan Plasma Protein Therapeutics Market by Product Type
7.3.4.2.3 Japan Plasma Protein Therapeutics Market by Application
7.3.4.3 India Plasma Protein Therapeutics Market
7.3.4.3.1 India Plasma Protein Therapeutics Market by End User
7.3.4.3.2 India Plasma Protein Therapeutics Market by Product Type
7.3.4.3.3 India Plasma Protein Therapeutics Market by Application
7.3.4.4 South Korea Plasma Protein Therapeutics Market
7.3.4.4.1 South Korea Plasma Protein Therapeutics Market by End User
7.3.4.4.2 South Korea Plasma Protein Therapeutics Market by Product Type
7.3.4.4.3 South Korea Plasma Protein Therapeutics Market by Application
7.3.4.5 Singapore Plasma Protein Therapeutics Market
7.3.4.5.1 Singapore Plasma Protein Therapeutics Market by End User
7.3.4.5.2 Singapore Plasma Protein Therapeutics Market by Product Type
7.3.4.5.3 Singapore Plasma Protein Therapeutics Market by Application
7.3.4.6 Malaysia Plasma Protein Therapeutics Market
7.3.4.6.1 Malaysia Plasma Protein Therapeutics Market by End User
7.3.4.6.2 Malaysia Plasma Protein Therapeutics Market by Product Type
7.3.4.6.3 Malaysia Plasma Protein Therapeutics Market by Application
7.3.4.7 Rest of Asia Pacific Plasma Protein Therapeutics Market
7.3.4.7.1 Rest of Asia Pacific Plasma Protein Therapeutics Market by End User
7.3.4.7.2 Rest of Asia Pacific Plasma Protein Therapeutics Market by Product Type
7.3.4.7.3 Rest of Asia Pacific Plasma Protein Therapeutics Market by Application
7.4 LAMEA Plasma Protein Therapeutics Market
7.4.1 LAMEA Plasma Protein Therapeutics Market by End User
7.4.1.1 LAMEA Hospitals Market by Country
7.4.1.2 LAMEA Others Market by Country
7.4.2 LAMEA Plasma Protein Therapeutics Market by Product Type
7.4.2.1 LAMEA Immunoglobulin Market by Country
7.4.2.2 LAMEA Albumin Market by Country
7.4.2.3 LAMEA Plasma derived factor VIII Market by Country
7.4.2.4 LAMEA Others Market by Country
7.4.3 LAMEA Plasma Protein Therapeutics Market by Application
7.4.3.1 LAMEA Hemophilia Market by Country
7.4.3.2 LAMEA Idiopathic Thrombocytopenic Purpura Market by Country
7.4.3.3 LAMEA Primary Immunodeficiency Disorder Market by Country
7.4.3.4 LAMEA Others Market by Country
7.4.4 LAMEA Plasma Protein Therapeutics Market by Country
7.4.4.1 Brazil Plasma Protein Therapeutics Market
7.4.4.1.1 Brazil Plasma Protein Therapeutics Market by End User
7.4.4.1.2 Brazil Plasma Protein Therapeutics Market by Product Type
7.4.4.1.3 Brazil Plasma Protein Therapeutics Market by Application
7.4.4.2 Argentina Plasma Protein Therapeutics Market
7.4.4.2.1 Argentina Plasma Protein Therapeutics Market by End User
7.4.4.2.2 Argentina Plasma Protein Therapeutics Market by Product Type
7.4.4.2.3 Argentina Plasma Protein Therapeutics Market by Application
7.4.4.3 UAE Plasma Protein Therapeutics Market
7.4.4.3.1 UAE Plasma Protein Therapeutics Market by End User
7.4.4.3.2 UAE Plasma Protein Therapeutics Market by Product Type
7.4.4.3.3 UAE Plasma Protein Therapeutics Market by Application
7.4.4.4 Saudi Arabia Plasma Protein Therapeutics Market
7.4.4.4.1 Saudi Arabia Plasma Protein Therapeutics Market by End User
7.4.4.4.2 Saudi Arabia Plasma Protein Therapeutics Market by Product Type
7.4.4.4.3 Saudi Arabia Plasma Protein Therapeutics Market by Application
7.4.4.5 South Africa Plasma Protein Therapeutics Market
7.4.4.5.1 South Africa Plasma Protein Therapeutics Market by End User
7.4.4.5.2 South Africa Plasma Protein Therapeutics Market by Product Type
7.4.4.5.3 South Africa Plasma Protein Therapeutics Market by Application
7.4.4.6 Nigeria Plasma Protein Therapeutics Market
7.4.4.6.1 Nigeria Plasma Protein Therapeutics Market by End User
7.4.4.6.2 Nigeria Plasma Protein Therapeutics Market by Product Type
7.4.4.6.3 Nigeria Plasma Protein Therapeutics Market by Application
7.4.4.7 Rest of LAMEA Plasma Protein Therapeutics Market
7.4.4.7.1 Rest of LAMEA Plasma Protein Therapeutics Market by End User
7.4.4.7.2 Rest of LAMEA Plasma Protein Therapeutics Market by Product Type
7.4.4.7.3 Rest of LAMEA Plasma Protein Therapeutics Market by Application

Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Grifols, S.A
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.5.3 Acquisition and Mergers:
8.2.5.4 Geographical Expansions:
8.3 Takeda Pharmaceutical Company Limited
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.3.5.3 Geographical Expansions:
8.4 Kedrion S.p.A
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisition and Mergers:
8.5 ADMA Biologics, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Approvals and Trials:
8.6 Octapharma AG
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 Recent strategies and developments:
8.6.4.1 Approvals and Trials:
8.7 CSL Limited (CSL Behring)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.8 Baxter International, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 Research & Development Expense
8.9 Abeona Therapeutics, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Research & Development Expenses
8.10. Taibang Biologic Group
8.10.1 Company Overview

TABLE 1 Global Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 2 Global Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Plasma Protein Therapeutics Market
TABLE 4 Product Launches And Product Expansions– Plasma Protein Therapeutics Market
TABLE 5 Acquisition and Mergers– Plasma Protein Therapeutics Market
TABLE 6 Geographical expansions – Plasma Protein Therapeutics Market
TABLE 7 approvals and trials – Plasma Protein Therapeutics Market
TABLE 8 Global Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 9 Global Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 10 Global Hospitals Market by Region, 2019 - 2022, USD Million
TABLE 11 Global Hospitals Market by Region, 2023 - 2029, USD Million
TABLE 12 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 13 Global Others Market by Region, 2023 - 2029, USD Million
TABLE 14 Global Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 15 Global Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 16 Global Immunoglobulin Market by Region, 2019 - 2022, USD Million
TABLE 17 Global Immunoglobulin Market by Region, 2023 - 2029, USD Million
TABLE 18 Global Albumin Market by Region, 2019 - 2022, USD Million
TABLE 19 Global Albumin Market by Region, 2023 - 2029, USD Million
TABLE 20 Global Plasma derived factor VIII Market by Region, 2019 - 2022, USD Million
TABLE 21 Global Plasma derived factor VIII Market by Region, 2023 - 2029, USD Million
TABLE 22 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 23 Global Others Market by Region, 2023 - 2029, USD Million
TABLE 24 Global Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 25 Global Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 26 Global Hemophilia Market by Region, 2019 - 2022, USD Million
TABLE 27 Global Hemophilia Market by Region, 2023 - 2029, USD Million
TABLE 28 Global Idiopathic Thrombocytopenic Purpura Market by Region, 2019 - 2022, USD Million
TABLE 29 Global Idiopathic Thrombocytopenic Purpura Market by Region, 2023 - 2029, USD Million
TABLE 30 Global Primary Immunodeficiency Disorder Market by Region, 2019 - 2022, USD Million
TABLE 31 Global Primary Immunodeficiency Disorder Market by Region, 2023 - 2029, USD Million
TABLE 32 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 33 Global Others Market by Region, 2023 - 2029, USD Million
TABLE 34 Global Plasma Protein Therapeutics Market by Region, 2019 - 2022, USD Million
TABLE 35 Global Plasma Protein Therapeutics Market by Region, 2023 - 2029, USD Million
TABLE 36 North America Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 37 North America Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 38 North America Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 39 North America Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 40 North America Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 41 North America Hospitals Market by Country, 2023 - 2029, USD Million
TABLE 42 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 43 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 44 North America Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 45 North America Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 46 North America Immunoglobulin Market by Country, 2019 - 2022, USD Million
TABLE 47 North America Immunoglobulin Market by Country, 2023 - 2029, USD Million
TABLE 48 North America Albumin Market by Country, 2019 - 2022, USD Million
TABLE 49 North America Albumin Market by Country, 2023 - 2029, USD Million
TABLE 50 North America Plasma derived factor VIII Market by Country, 2019 - 2022, USD Million
TABLE 51 North America Plasma derived factor VIII Market by Country, 2023 - 2029, USD Million
TABLE 52 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 53 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 54 North America Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 55 North America Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 56 North America Hemophilia Market by Country, 2019 - 2022, USD Million
TABLE 57 North America Hemophilia Market by Country, 2023 - 2029, USD Million
TABLE 58 North America Idiopathic Thrombocytopenic Purpura Market by Country, 2019 - 2022, USD Million
TABLE 59 North America Idiopathic Thrombocytopenic Purpura Market by Country, 2023 - 2029, USD Million
TABLE 60 North America Primary Immunodeficiency Disorder Market by Country, 2019 - 2022, USD Million
TABLE 61 North America Primary Immunodeficiency Disorder Market by Country, 2023 - 2029, USD Million
TABLE 62 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 63 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 64 North America Plasma Protein Therapeutics Market by Country, 2019 - 2022, USD Million
TABLE 65 North America Plasma Protein Therapeutics Market by Country, 2023 - 2029, USD Million
TABLE 66 US Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 67 US Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 68 US Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 69 US Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 70 US Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 71 US Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 72 US Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 73 US Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 74 Canada Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 75 Canada Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 76 Canada Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 77 Canada Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 78 Canada Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 79 Canada Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 80 Canada Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 81 Canada Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 82 Mexico Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 83 Mexico Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 84 Mexico Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 85 Mexico Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 86 Mexico Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 87 Mexico Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 88 Mexico Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 89 Mexico Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 90 Rest of North America Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 91 Rest of North America Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 92 Rest of North America Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 93 Rest of North America Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 94 Rest of North America Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 95 Rest of North America Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 96 Rest of North America Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 97 Rest of North America Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 98 Europe Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 99 Europe Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 100 Europe Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 101 Europe Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 102 Europe Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 103 Europe Hospitals Market by Country, 2023 - 2029, USD Million
TABLE 104 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 105 Europe Others Market by Country, 2023 - 2029, USD Million
TABLE 106 Europe Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 107 Europe Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 108 Europe Immunoglobulin Market by Country, 2019 - 2022, USD Million
TABLE 109 Europe Immunoglobulin Market by Country, 2023 - 2029, USD Million
TABLE 110 Europe Albumin Market by Country, 2019 - 2022, USD Million
TABLE 111 Europe Albumin Market by Country, 2023 - 2029, USD Million
TABLE 112 Europe Plasma derived factor VIII Market by Country, 2019 - 2022, USD Million
TABLE 113 Europe Plasma derived factor VIII Market by Country, 2023 - 2029, USD Million
TABLE 114 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 115 Europe Others Market by Country, 2023 - 2029, USD Million
TABLE 116 Europe Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 117 Europe Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 118 Europe Hemophilia Market by Country, 2019 - 2022, USD Million
TABLE 119 Europe Hemophilia Market by Country, 2023 - 2029, USD Million
TABLE 120 Europe Idiopathic Thrombocytopenic Purpura Market by Country, 2019 - 2022, USD Million
TABLE 121 Europe Idiopathic Thrombocytopenic Purpura Market by Country, 2023 - 2029, USD Million
TABLE 122 Europe Primary Immunodeficiency Disorder Market by Country, 2019 - 2022, USD Million
TABLE 123 Europe Primary Immunodeficiency Disorder Market by Country, 2023 - 2029, USD Million
TABLE 124 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 125 Europe Others Market by Country, 2023 - 2029, USD Million
TABLE 126 Europe Plasma Protein Therapeutics Market by Country, 2019 - 2022, USD Million
TABLE 127 Europe Plasma Protein Therapeutics Market by Country, 2023 - 2029, USD Million
TABLE 128 Germany Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 129 Germany Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 130 Germany Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 131 Germany Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 132 Germany Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 133 Germany Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 134 Germany Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 135 Germany Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 136 UK Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 137 UK Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 138 UK Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 139 UK Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 140 UK Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 141 UK Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 142 UK Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 143 UK Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 144 France Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 145 France Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 146 France Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 147 France Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 148 France Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 149 France Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 150 France Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 151 France Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 152 Russia Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 153 Russia Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 154 Russia Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 155 Russia Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 156 Russia Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 157 Russia Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 158 Russia Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 159 Russia Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 160 Spain Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 161 Spain Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 162 Spain Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 163 Spain Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 164 Spain Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 165 Spain Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 166 Spain Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 167 Spain Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 168 Italy Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 169 Italy Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 170 Italy Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 171 Italy Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 172 Italy Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 173 Italy Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 174 Italy Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 175 Italy Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 176 Rest of Europe Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 177 Rest of Europe Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 178 Rest of Europe Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 179 Rest of Europe Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 180 Rest of Europe Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 181 Rest of Europe Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 182 Rest of Europe Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 183 Rest of Europe Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 184 Asia Pacific Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 185 Asia Pacific Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 186 Asia Pacific Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 187 Asia Pacific Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 188 Asia Pacific Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 189 Asia Pacific Hospitals Market by Country, 2023 - 2029, USD Million
TABLE 190 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 191 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
TABLE 192 Asia Pacific Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 193 Asia Pacific Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 194 Asia Pacific Immunoglobulin Market by Country, 2019 - 2022, USD Million
TABLE 195 Asia Pacific Immunoglobulin Market by Country, 2023 - 2029, USD Million
TABLE 196 Asia Pacific Albumin Market by Country, 2019 - 2022, USD Million
TABLE 197 Asia Pacific Albumin Market by Country, 2023 - 2029, USD Million
TABLE 198 Asia Pacific Plasma derived factor VIII Market by Country, 2019 - 2022, USD Million
TABLE 199 Asia Pacific Plasma derived factor VIII Market by Country, 2023 - 2029, USD Million
TABLE 200 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 201 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
TABLE 202 Asia Pacific Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 203 Asia Pacific Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 204 Asia Pacific Hemophilia Market by Country, 2019 - 2022, USD Million
TABLE 205 Asia Pacific Hemophilia Market by Country, 2023 - 2029, USD Million
TABLE 206 Asia Pacific Idiopathic Thrombocytopenic Purpura Market by Country, 2019 - 2022, USD Million
TABLE 207 Asia Pacific Idiopathic Thrombocytopenic Purpura Market by Country, 2023 - 2029, USD Million
TABLE 208 Asia Pacific Primary Immunodeficiency Disorder Market by Country, 2019 - 2022, USD Million
TABLE 209 Asia Pacific Primary Immunodeficiency Disorder Market by Country, 2023 - 2029, USD Million
TABLE 210 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 211 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
TABLE 212 Asia Pacific Plasma Protein Therapeutics Market by Country, 2019 - 2022, USD Million
TABLE 213 Asia Pacific Plasma Protein Therapeutics Market by Country, 2023 - 2029, USD Million
TABLE 214 China Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 215 China Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 216 China Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 217 China Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 218 China Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 219 China Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 220 China Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 221 China Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 222 Japan Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 223 Japan Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 224 Japan Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 225 Japan Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 226 Japan Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 227 Japan Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 228 Japan Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 229 Japan Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 230 India Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 231 India Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 232 India Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 233 India Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 234 India Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 235 India Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 236 India Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 237 India Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 238 South Korea Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 239 South Korea Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 240 South Korea Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 241 South Korea Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 242 South Korea Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 243 South Korea Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 244 South Korea Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 245 South Korea Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 246 Singapore Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 247 Singapore Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 248 Singapore Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 249 Singapore Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 250 Singapore Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 251 Singapore Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 252 Singapore Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 253 Singapore Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 254 Malaysia Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 255 Malaysia Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 256 Malaysia Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 257 Malaysia Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 258 Malaysia Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 259 Malaysia Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 260 Malaysia Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 261 Malaysia Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 262 Rest of Asia Pacific Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 263 Rest of Asia Pacific Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 264 Rest of Asia Pacific Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 265 Rest of Asia Pacific Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 266 Rest of Asia Pacific Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 267 Rest of Asia Pacific Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 268 Rest of Asia Pacific Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 269 Rest of Asia Pacific Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 270 LAMEA Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 271 LAMEA Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 272 LAMEA Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 273 LAMEA Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 274 LAMEA Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 275 LAMEA Hospitals Market by Country, 2023 - 2029, USD Million
TABLE 276 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 277 LAMEA Others Market by Country, 2023 - 2029, USD Million
TABLE 278 LAMEA Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 279 LAMEA Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 280 LAMEA Immunoglobulin Market by Country, 2019 - 2022, USD Million
TABLE 281 LAMEA Immunoglobulin Market by Country, 2023 - 2029, USD Million
TABLE 282 LAMEA Albumin Market by Country, 2019 - 2022, USD Million
TABLE 283 LAMEA Albumin Market by Country, 2023 - 2029, USD Million
TABLE 284 LAMEA Plasma derived factor VIII Market by Country, 2019 - 2022, USD Million
TABLE 285 LAMEA Plasma derived factor VIII Market by Country, 2023 - 2029, USD Million
TABLE 286 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 287 LAMEA Others Market by Country, 2023 - 2029, USD Million
TABLE 288 LAMEA Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 289 LAMEA Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 290 LAMEA Hemophilia Market by Country, 2019 - 2022, USD Million
TABLE 291 LAMEA Hemophilia Market by Country, 2023 - 2029, USD Million
TABLE 292 LAMEA Idiopathic Thrombocytopenic Purpura Market by Country, 2019 - 2022, USD Million
TABLE 293 LAMEA Idiopathic Thrombocytopenic Purpura Market by Country, 2023 - 2029, USD Million
TABLE 294 LAMEA Primary Immunodeficiency Disorder Market by Country, 2019 - 2022, USD Million
TABLE 295 LAMEA Primary Immunodeficiency Disorder Market by Country, 2023 - 2029, USD Million
TABLE 296 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 297 LAMEA Others Market by Country, 2023 - 2029, USD Million
TABLE 298 LAMEA Plasma Protein Therapeutics Market by Country, 2019 - 2022, USD Million
TABLE 299 LAMEA Plasma Protein Therapeutics Market by Country, 2023 - 2029, USD Million
TABLE 300 Brazil Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 301 Brazil Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 302 Brazil Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 303 Brazil Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 304 Brazil Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 305 Brazil Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 306 Brazil Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 307 Brazil Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 308 Argentina Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 309 Argentina Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 310 Argentina Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 311 Argentina Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 312 Argentina Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 313 Argentina Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 314 Argentina Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 315 Argentina Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 316 UAE Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 317 UAE Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 318 UAE Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 319 UAE Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 320 UAE Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 321 UAE Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 322 UAE Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 323 UAE Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 324 Saudi Arabia Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 325 Saudi Arabia Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 326 Saudi Arabia Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 327 Saudi Arabia Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 328 Saudi Arabia Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 329 Saudi Arabia Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 330 Saudi Arabia Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 331 Saudi Arabia Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 332 South Africa Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 333 South Africa Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 334 South Africa Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 335 South Africa Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 336 South Africa Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 337 South Africa Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 338 South Africa Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 339 South Africa Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 340 Nigeria Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 341 Nigeria Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 342 Nigeria Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 343 Nigeria Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 344 Nigeria Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 345 Nigeria Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 346 Nigeria Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 347 Nigeria Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 348 Rest of LAMEA Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 349 Rest of LAMEA Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 350 Rest of LAMEA Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 351 Rest of LAMEA Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 352 Rest of LAMEA Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 353 Rest of LAMEA Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 354 Rest of LAMEA Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 355 Rest of LAMEA Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 356 Key Information – Bayer AG
TABLE 357 Key information – Grifols, S.A.
TABLE 358 Key Information – Takeda Pharmaceutical Company Limited
TABLE 359 key Information – Kedrion S.p.A
TABLE 360 Key Information – ADMA Biologics, Inc.
TABLE 361 Key Information – Octapharma AG
TABLE 362 key Information – CSL Limited
TABLE 363 Key Information – Baxter International, Inc.
TABLE 364 Key Information – Abeona Therapeutics, Inc.
TABLE 365 Key Information – Taibang Biologic Group

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Key Strategic Move: (Acquisitions and Mergers : 2020, Jun – 2023, Mar) Leading Players
FIG 5 Global Plasma Protein Therapeutics Market share, by End User, 2022
FIG 6 Global Plasma Protein Therapeutics Market share, by End User, 2029
FIG 7 Global Plasma Protein Therapeutics Market by End User, 2019 - 2029, USD Million
FIG 8 Global Plasma Protein Therapeutics Market share, by Product Type, 2022
FIG 9 Global Plasma Protein Therapeutics Market share, by Product Type, 2029
FIG 10 Global Plasma Protein Therapeutics Market by Product Type, 2019 - 2029, USD Million
FIG 11 Global Plasma Protein Therapeutics Market share by Application, 2022
FIG 12 Global Plasma Protein Therapeutics Market share by Application, 2029
FIG 13 Global Plasma Protein Therapeutics Market by Application, 2019 - 2029, USD Million
FIG 14 Global Plasma Protein Therapeutics Market share, by Region, 2022
FIG 15 Global Plasma Protein Therapeutics Market share, by Region, 2029
FIG 16 Global Plasma Protein Therapeutics Market by Region, 2019 - 2029, USD Million
FIG 17 Swot analysis: bayer ag
FIG 18 Recent strategies and developments: Grifols, S.A.
FIG 19 Recent strategies and developments: Takeda Pharmaceutical Company Limited
FIG 20 Recent strategies and developments: Kedrion S.p.A